Seminars in Arthritis and Rheumatism
Volume 40, Issue 2 , Pages 164-175 , October 2010

The Involvement of Heat-Shock Proteins in the Pathogenesis of Autoimmune Arthritis: A Critical Appraisal

  • Min-Nung Huang, MD

      Affiliations

    • Graduate student, Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland
    • ,
  • Hua Yu, MD

      Affiliations

    • Postdoctoral fellow, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
    • ,
  • Kamal D. Moudgil, MD, PhD

      Affiliations

    • Associate Professor, Department of Microbiology and Immunology, Division of Rheumatology, Department of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
    • Corresponding Author InformationAddress reprint requests to: Kamal D. Moudgil, MD, PhD, Department of Microbiology and Immunology, University of Maryland School of Medicine, Howard Hall 318B, 660 W. Redwood St., Baltimore, MD 21201

References 

  1. Lipsky PE. Rheumatoid arthritis. In:  Kasper D,  Braunwald E,  Fauci A,  Hauser S,  Longo D,  Jameson J editor. Harrison's Principles of Internal Medicine. 16th edition. New York (NY): McGraw-Hill; 2005;p. 1968–1977
  2. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum. 1998;41(5):778–799
  3. Harris ED. Rheumatoid arthritis (Pathophysiology and implications for therapy). N Engl J Med. 1990;322(18):1277–1289
  4. Lindquist S, Craig EA. The heat-shock proteins. Annu Rev Genet. 1988;22:631–677
  5. Ranson NA, White HE, Saibil HR. Chaperonins Biochem J. 1998;333(Pt. 2):233–242
  6. Srivastava P. Roles of heat-shock proteins in innate and adaptive immunity. Nat Rev Immunol. 2002;2(3):185–194
  7. Chang HC, Tang YC, Hayer-Hartl M, Hartl FU. SnapShot: molecular chaperones. Part I (Cell). 2007;128(1):212
  8. Holoshitz J, Naparstek Y, Ben-Nun A, Cohen IR. Lines of T lymphocytes induce or vaccinate against autoimmune arthritis. Science. 1983;219(4580):56–58
  9. van Eden W, Thole JE, van der Zee R, Noordzij A, van Embden JD, Hensen EJ, et al. Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature. 1988;331(6152):171–173
  10. Quintana FJ, Carmi P, Mor F, Cohen IR. Inhibition of adjuvant arthritis by a DNA vaccine encoding human heat shock protein 60. J Immunol. 2002;169(6):3422–3428
  11. Moudgil KD, Chang TT, Eradat H, Chen AM, Gupta RS, Brahn E, et al. Diversification of T cell responses to carboxy-terminal determinants within the 65-kD heat-shock protein is involved in regulation of autoimmune arthritis. J Exp Med. 1997;185(7):1307–1316
  12. Ulmansky R, Cohen CJ, Szafer F, Moallem E, Fridlender ZG, Kashi Y, et al. Resistance to adjuvant arthritis is due to protective antibodies against heat shock protein surface epitopes and the induction of IL-10 secretion. J Immunol. 2002;168(12):6463–6469
  13. Thompson SJ, Butcher PD, Patel VK, Rook GA, Stanford J, van der Zee R, et al. Modulation of pristane-induced arthritis by mycobacterial antigens. Autoimmunity. 1991;11(1):35–43
  14. van den Broek MF, Hogervorst EJ, Van Bruggen MC, Van Eden W, van der Zee R, van den Berg WB. Protection against streptococcal cell wall-induced arthritis by pretreatment with the 65-kD mycobacterial heat shock protein. J Exp Med. 1989;170(2):449–466
  15. Mia MY, Durai M, Kim HR, Moudgil KD. Heat shock protein 65-reactive T cells are involved in the pathogenesis of non-antigenic dimethyl dioctadecyl ammonium bromide-induced arthritis. J Immunol. 2005;175(1):219–227
  16. Francis JN, Lamont AG, Thompson SJ. The route of administration of an immunodominant peptide derived from heat-shock protein 65 dramatically affects disease outcome in pristane-induced arthritis. Immunology. 2000;99(3):338–344
  17. Hromadnikova I, Nguyen TT, Zlacka D, Sedlackova L, Popelka S, Veigl D, et al. Expression of heat shock protein receptors on fibroblast-like synovial cells derived from rheumatoid arthritis-affected joints. Rheumatol Int. 2008;28(9):837–844
  18. Rice JW, Veal JM, Fadden RP, Barabasz AF, Partridge JM, Barta TE, et al. Small molecule inhibitors of Hsp90 potently affect inflammatory disease pathways and exhibit activity in models of rheumatoid arthritis. Arthritis Rheum. 2008;58(12):3765–3775
  19. Erlandsson Harris H, Liljestrom M, Klareskog L. Characteristics of synovial fluid effusion in collagen-induced arthritis (CIA) in the DA rat; a comparison of histology and antibody reactivities in an experimental chronic arthritis model and rheumatoid arthritis (RA). Clin Exp Immunol. 1997;107(3):480–484
  20. Bodman-Smith MD, Corrigall VM, Berglin E, Cornell HR, Tzioufas AG, Mavragani CP, et al. Antibody response to the human stress protein BiP in rheumatoid arthritis. Rheumatology (Oxford). 2004;43(10):1283–1287
  21. Zlacka D, Vavrincova P, Hien Nguyen TT, Hromadnikova I. Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis. J Autoimmun. 2006;27(2):81–88
  22. Kim HR, Kim EY, Cerny J, Moudgil KD. Antibody responses to mycobacterial and self heat shock protein 65 in autoimmune arthritis: epitope specificity and implication in pathogenesis. J Immunol. 2006;177(10):6634–6641
  23. Miletic T, Kovacevic-Jovanovic V, Stanojevic S, Vujic V, Kosec D, Mitic K, et al. Strain differences and the role for HSP47 and HSP70 in adjuvant arthritis in rats. Scand J Immunol. 2006;64(6):623–632
  24. Schultz DR, Arnold PI. Heat shock (stress) proteins and autoimmunity in rheumatic diseases. Semin Arthritis Rheum. 1993;22(6):357–374
  25. Pearson CM. Development of arthritis, periarthritis and periostitis in rats given adjuvants. Proc Soc Exp Biol Med. 1956;91(1):95–101
  26. Wilder RL. Streptococcal cell-wall-induced arthritis in rats: an overview. Int J Tissue React. 1988;10(1):1–5
  27. Song XY, Zeng L, Jin W, Pilo CM, Frank ME, Wahl SM. Suppression of streptococcal cell wall-induced arthritis by human chorionic gonadotropin. Arthritis Rheum. 2000;43(9):2064–2072
  28. Thompson SJ, Francis JN, Siew LK, Webb GR, Jenner PJ, Colston MJ, et al. An immunodominant epitope from mycobacterial 65-kDa heat shock protein protects against pristane-induced arthritis. J Immunol. 1998;160(9):4628–4634
  29. Kingston AE, Hicks CA, Colston MJ, Billingham ME. A 71-kD heat shock protein (hsp) from Mycobacterium tuberculosis has modulatory effects on experimental rat arthritis. Clin Exp Immunol. 1996;103(1):77–82
  30. Prakken BJ, van der Zee R, Anderton SM, van Kooten PJ, Kuis W, van Eden W. Peptide-induced nasal tolerance for a mycobacterial heat shock protein 60 T cell epitope in rats suppresses both adjuvant arthritis and nonmicrobially induced experimental arthritis. Proc Natl Acad Sci USA. 1997;94(7):3284–3289
  31. Wendling U, Paul L, van der Zee R, Prakken B, Singh M, van Eden W. A conserved mycobacterial heat shock protein (hsp) 70 sequence prevents adjuvant arthritis upon nasal administration and induces IL-10-producing T cells that cross-react with the mammalian self-hsp70 homologue. J Immunol. 2000;164(5):2711–2717
  32. Quintana FJ, Carmi P, Mor F, Cohen IR. Inhibition of adjuvant-induced arthritis by DNA vaccination with the 70-kd or the 90-kd human heat-shock protein: immune cross-regulation with the 60-kd heat-shock protein. Arthritis Rheum. 2004;50(11):3712–3720
  33. Satpute SR, Rajaiah R, Polumuri SK, Moudgil KD. Tolerization with Hsp65 induces protection against adjuvant-induced arthritis by modulating the antigen-directed interferon-gamma, interleukin-17, and antibody responses. Arthritis Rheum. 2009;60(1):103–113
  34. Ragno S, Winrow VR, Mascagni P, Lucietto P, Di Pierro F, Morris CJ, et al. A synthetic 10-kD heat shock protein (hsp10) from Mycobacterium tuberculosis modulates adjuvant arthritis. Clin Exp Immunol. 1996;103(3):384–390
  35. Agnello D, Scanziani E, Di GM, Leoni F, Modena D, Mascagni P, et al. Preventive administration of Mycobacterium tuberculosis 10-kDa heat shock protein (hsp10) suppresses adjuvant arthritis in Lewis rats. Int Immunopharmacol. 2002;2(4):463–474
  36. Brownlie RJ, Myers LK, Wooley PH, Corrigall VM, Bodman-Smith MD, Panayi GS, et al. Treatment of murine collagen-induced arthritis by the stress protein BiP via interleukin-4-producing regulatory T cells: a novel function for an ancient protein. Arthritis Rheum. 2006;54(3):854–863
  37. Jorgensen C, Gedon E, Jaquet C, Sany J. Gastric administration of recombinant 65 kDa heat shock protein delays the severity of type II collagen induced arthritis in mice. J Rheumatol. 1998;25(4):763–767
  38. Xiao J, Li S, Wang W, Li Y, Zhao W. Protective effects of overexpression TCR Vbeta5.2-HSP70 and TCR Vbeta8.2-HSP70 against collagen-induced arthritis in rats. Cell Mol Immunol. 2007;4(6):439–445
  39. Anderton SM, van der Zee R, Noordzij A, van Eden W. Differential mycobacterial 65-kDa heat shock protein T cell epitope recognition after adjuvant arthritis-inducing or protective immunization protocols. J Immunol. 1994;152(7):3656–3664
  40. Anderton SM, van der Zee R, Prakken B, Noordzij A, van Eden W. Activation of T cells recognizing self 60-kD heat shock protein can protect against experimental arthritis. J Exp Med. 1995;181(3):943–952
  41. Durai M, Kim HR, Moudgil KD. The regulatory C-terminal determinants within mycobacterial heat shock protein 65 are cryptic and cross-reactive with the dominant self homologs: implications for the pathogenesis of autoimmune arthritis. J Immunol. 2004;173(1):181–188
  42. Wendling U, Bloemendal A, Van Der Zee R, Rutten VP, Van Kooten PJ, Farine JC, et al. Antirheumatic E. coli extract OM-89 induces T cell responses to HSP60 and 70. Int J Immunopharmacol. 1997;19(9-10):565–568
  43. Durai M, Gupta RS, Moudgil KD. The T cells specific for the carboxyl-terminal determinants of self (rat) heat-shock protein 65 escape tolerance induction and are involved in regulation of autoimmune arthritis. J Immunol. 2004;172(5):2795–2802
  44. Billingham ME, Carney S, Butler R, Colston MJ. A mycobacterial 65-kD heat shock protein induces antigen-specific suppression of adjuvant arthritis, but is not itself arthritogenic. J Exp Med. 1990;171(1):339–344
  45. Kohashi O, Kohashi Y, Takahashi T, Ozawa A, Shigematsu N. Reverse effect of gram-positive bacteria vs. gram-negative bacteria on adjuvant-induced arthritis in germfree rats. Microbiol Immunol. 1985;29(6):487–497
  46. Kohashi O, Kohashi Y, Takahashi T, Ozawa A, Shigematsu N. Suppressive effect of Escherichia coli on adjuvant-induced arthritis in germ-free rats. Arthritis Rheum. 1986;29(4):547–553
  47. Quadri SA, Taneja V, Mehra NK, Singal DP. HSP70-1 promoter region alleles and susceptibility to rheumatoid arthritis. Clin Exp Rheumatol. 1996;14(2):183–185
  48. Rueda B, Oliver J, Robledo G, Lopez-Nevot MA, Balsa A, Pascual-Salcedo D, et al. HO-1 promoter polymorphism associated with rheumatoid arthritis. Arthritis Rheum. 2007;56(12):3953–3958
  49. Singal DP, Li J, Zhu Y. HLA class III region and susceptibility to rheumatoid arthritis. Clin Exp Rheumatol. 2000;18(4):485–491
  50. Wagener FA, Toonen EJ, Wigman L, Fransen J, Creemers MC, Radstake TR, et al. HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis. Arthritis Rheum. 2008;58(11):3388–3393
  51. Jenkins SC, March RE, Campbell RD, Milner CM. A novel variant of the MHC-linked hsp70, hsp70-hom, is associated with rheumatoid arthritis. Tissue Antigens. 2000;56(1):38–44
  52. Jacq L, Teixeira VH, Garnier S, Michou L, Dieude P, Rocha D, et al. HSPD1 is not a major susceptibility gene for rheumatoid arthritis in the French Caucasian population. J Hum Genet. 2007;52(12):1036–1039
  53. Vinasco J, Beraun Y, Nieto A, Fraile A, Pareja E, Mataran L, et al. Heat shock protein 70 gene polymorphisms in rheumatoid arthritis. Tissue Antigens. 1997;50(1):71–73
  54. Auger I, Escola JM, Gorvel JP, Roudier J. HLA-DR4 and HLA-DR10 motifs that carry susceptibility to rheumatoid arthritis bind 70-kD heat shock proteins. Nat Med. 1996;2(3):306–310
  55. Albani S, Tuckwell JE, Esparza L, Carson DA, Roudier J. The susceptibility sequence to rheumatoid arthritis is a cross-reactive B cell epitope shared by the Escherichia coli heat shock protein dnaJ and the histocompatibility leukocyte antigen DRB10401 molecule. J Clin Invest. 1992;89(1):327–331
  56. Auger I, Lepecuchel L, Roudier J. Interaction between heat-shock protein 73 and HLA-DRB1 alleles associated or not with rheumatoid arthritis. Arthritis Rheum. 2002;46(4):929–933
  57. Auger I, Roudier J. A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK (Implications for the association of rheumatoid arthritis with HLA-DR4). J Clin Invest. 1997;99(8):1818–1822
  58. Albani S, Keystone EC, Nelson JL, Ollier WE, La Cava A, Montemayor AC, et al. Positive selection in autoimmunity: abnormal immune responses to a bacterial dnaJ antigenic determinant in patients with early rheumatoid arthritis. Nat Med. 1995;1(5):448–452
  59. Maier JT, Haug M, Foll JL, Beck H, Kalbacher H, Rammensee HG, et al. Possible association of non-binding of HSP70 to HLA-DRB1 peptide sequences and protection from rheumatoid arthritis. Immunogenetics. 2002;54(2):67–73
  60. Alcaraz MJ, Fernandez P, Guillen MI. Anti-inflammatory actions of the heme oxygenase-1 pathway. Curr Pharm Des. 2003;9(30):2541–2551
  61. Huang QQ, Sobkoviak R, Jockheck-Clark AR, Shi B, Mandelin AM, Tak PP, et al. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. J Immunol. 2009;182(8):4965–4973
  62. Nanke Y, Kawamoto M, Yago T, Chiba J, Yamanaka H, Kotake S. Geranylgeranylacetone, a non-toxic inducer of heat shock protein, induces cell death in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Mod Rheumatol. 2009;19(4):379–383
  63. Burmester GR, Altstidl U, Kalden JR, Emmrich F. Stimulatory response towards the 65 kDa heat shock protein and other mycobacterial antigens in patients with rheumatoid arthritis. J Rheumatol. 1991;18(2):171–176
  64. Celis L, Vandevyver C, Geusens P, Dequeker J, Raus J, Zhang J. Clonal expansion of mycobacterial heat-shock protein-reactive T lymphocytes in the synovial fluid and blood of rheumatoid arthritis patients. Arthritis Rheum. 1997;40(3):510–519
  65. Gaston JS, Life PF, van der Zee R, Jenner PJ, Colston MJ, Tonks S, et al. Epitope specificity and MHC restriction of rheumatoid arthritis synovial T cell clones which recognize a mycobacterial 65 kDa heat shock protein. Int Immunol. 1991;3(10):965–972
  66. Kogure A, Miyata M, Nishimaki T, Kasukawa R. Proliferative response of synovial fluid mononuclear cells of patients with rheumatoid arthritis to mycobacterial 65 kDa heat shock protein and its association with HLA-DR+.gamma delta+ T cells. J Rheumatol. 1994;21(8):1403–1408
  67. Lai NS, Lan JL, Yu CL, Lin RH. A dominant human leucocyte antigen DR4-Dw15 restricted mycobacterial 65 kDa antigen-specific T-cell immunity in Chinese patients with rheumatoid arthritis. Br J Rheumatol. 1995;34(6):498–506
  68. MacHt LM, Elson CJ, Kirwan JR, Gaston JS, Lamont AG, Thompson JM, et al. Relationship between disease severity and responses by blood mononuclear cells from patients with rheumatoid arthritis to human heat-shock protein 60. Immunology. 2000;99(2):208–214
  69. Melchers I, Jooss-Rudiger J, Peter HH. Reactivity patterns of synovial T-cell lines derived from a patient with rheumatoid arthritis. I (Reactions with defined antigens and auto-antigens suggest the existence of multireactive T-cell clones). Scand J Immunol. 1997;46(2):187–194
  70. Pope RM, Lovis RM, Gupta RS. Activation of synovial fluid T lymphocytes by 60-kd heat-shock proteins in patients with inflammatory synovitis. Arthritis Rheum. 1992;35(1):43–48
  71. Bahr GM, Rook GA, al-Saffar M, Van Embden J, Stanford JL, Behbehani K. Antibody levels to mycobacteria in relation to HLA type: evidence for non-HLA-linked high levels of antibody to the 65 kD heat shock protein of M. bovis in rheumatoid arthritis. Clin Exp Immunol. 1988;74(2):211–215
  72. van Roon JA, van Eden W, van Roy JL, Lafeber FJ, Bijlsma JW. Stimulation of suppressive T cell responses by human but not bacterial 60-kD heat-shock protein in synovial fluid of patients with rheumatoid arthritis. J Clin Invest. 1997;100(2):459–463
  73. Gaston JS, Life PF, Bailey LC, Bacon PA. In vitro responses to a 65-kilodalton mycobacterial protein by synovial T cells from inflammatory arthritis patients. J Immunol. 1989;143(8):2494–2500
  74. Li SG, Quayle AJ, Shen Y, Kjeldsen-Kragh J, Oftung F, Gupta RS, et al. Mycobacteria and human heat shock protein-specific cytotoxic T lymphocytes in rheumatoid synovial inflammation. Arthritis Rheum. 1992;35(3):270–281
  75. Prakken BJ, Samodal R, Le TD, Giannoni F, Yung GP, Scavulli J, et al. Epitope-specific immunotherapy induces immune deviation of proinflammatory T cells in rheumatoid arthritis. Proc Natl Acad Sci USA. 2004;101(12):4228–4233
  76. Blass S, Union A, Raymackers J, Schumann F, Ungethum U, Muller-Steinbach S, et al. The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis. Arthritis Rheum. 2001;44(4):761–771
  77. Corrigall VM, Bodman-Smith MD, Fife MS, Canas B, Myers LK, Wooley P, et al. The human endoplasmic reticulum molecular chaperone BiP is an autoantigen for rheumatoid arthritis and prevents the induction of experimental arthritis. J Immunol. 2001;166(3):1492–1498
  78. Zou J, Rudwaleit M, Thiel A, Lauster R, Braun J, Sieper J. T cell response to human HSP60 and yersinia 19 kDa in ankylosing spondylitis and rheumatoid arthritis: no evidence for a causal role of these antigens in the pathogenesis. Ann Rheum Dis. 2002;61(5):473–474
  79. Crick FD, Gatenby PA. Limiting-dilution analysis of T cell reactivity to mycobacterial antigens in peripheral blood and synovium from rheumatoid arthritis patients. Clin Exp Immunol. 1992;88(3):424–429
  80. Fischer HP, Sharrock CE, Colston MJ, Panayi GS. Limiting dilution analysis of proliferative T cell responses to mycobacterial 65-kDa heat-shock protein fails to show significant frequency differences between synovial fluid and peripheral blood of patients with rheumatoid arthritis. Eur J Immunol. 1991;21(12):2937–2941
  81. Sheikhi A, Nazarian M, Khadem-Al-Melleh A, Nasab NM, Esmaeilzadeh A, Yahaghi N, et al. In-vitro effects of Mycobacterium bovis BCG-lysate and its derived heat shock proteins on cytokines secretion by blood mononuclear cells of rheumatoid arthritis patients in comparison with healthy controls. Int Immunopharmacol. 2008;8(6):887–892
  82. Chukwuocha RU, Zhang B, Lai CJ, Scavulli JF, Albani S, Carson DA, et al. Isolation of an IgG monoclonal anti-dnaJ antibody from an immunoglobulin combinatorial library from a patient with rheumatoid arthritis. J Rheumatol. 1999;26(7):1439–1445
  83. Yoshida A, Nakano Y, Yamashita Y, Oho T, Ito H, Kondo M, et al. Immunodominant region of Actinobacillus actinomycetemcomitans 40-kilodalton heat shock protein in patients with rheumatoid arthritis. J Dent Res. 2001;80(1):346–350
  84. Hattori T, Takahash K, Yutani Y, Fujisawa T, Nakanishi T, Takigawa M. Rheumatoid arthritis-related antigen 47kDa (RA-A47) is a product of colligin-2 and acts as a human HSP47. J Bone Miner Metab. 2000;18(6):328–334
  85. Sakawa A, Yutani Y, Inui K, Shimazu A, Yamano Y, Kinosita A, et al. Specific serum antibodies against membranous proteins of a human immortal chondrocytic cell line (HCS-2/8) in rheumatoid arthritis and their relationship to the natural history of this disease. J Bone Miner Metab. 1996;14(3):146–152
  86. Tsoulfa G, Rook GA, Bahr GM, Sattar MA, Behbehani K, Young DB, et al. Elevated IgG antibody levels to the mycobacterial 65-kDa heat shock protein are characteristic of patients with rheumatoid arthritis. Scand J Immunol. 1989;30(5):519–527
  87. Adebajo AO, Williams DG, Hazleman BL, Maini RN. Antibodies to the 65 kDa mycobacterial stress protein in west Africans with rheumatoid arthritis, tuberculosis and malaria. Br J Rheumatol. 1995;34(4):352–354
  88. Hirata D, Hirai I, Iwamoto M, Yoshio T, Takeda A, Masuyama JI, et al. Preferential binding with Escherichia coli hsp60 of antibodies prevalent in sera from patients with rheumatoid arthritis. Clin Immunol Immunopathol. 1997;82(2):141–148
  89. Panchapakesan J, Daglis M, Gatenby P. Antibodies to 65 kDa and 70 kDa heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol. 1992;70(Pt. 5):295–300
  90. Rudolphi U, Rzepka R, Batsford S, Kaufmann SH, von der Mark K, Peter HH, et al. The B cell repertoire of patients with rheumatoid arthritis (II. Increased frequencies of IgG+ and IgA+ B cells specific for mycobacterial heat-shock protein 60 or human type II collagen in synovial fluid and tissue). Arthritis Rheum. 1997;40(8):1409–1419
  91. van Halm VP, Slot MC, Nurmohamed MT, Cohen Tervaert JW, Dijkmans BA, Voskuyl AE. Antibodies against human 60 kDa heat shock protein are not associated with cardiovascular disease in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(5):590–594
  92. Oda A, Miyata M, Kodama E, Satoh H, Sato Y, Nishimaki T, et al. Antibodies to 65Kd heat-shock protein were elevated in rheumatoid arthritis. Clin Rheumatol. 1994;13(2):261–264
  93. Mavropoulos JC, Cuchacovich M, Llanos C, Aguillon JC, Gatica H, Pizzo SV, et al. Anti-tumor necrosis factor-alpha therapy augments dipeptidyl peptidase IV activity and decreases autoantibodies to GRP78/BIP and phosphoglucose isomerase in patients with rheumatoid arthritis. J Rheumatol. 2005;32(11):2116–2124
  94. Hayem G, De Bandt M, Palazzo E, Roux S, Combe B, Eliaou JF, et al. Anti-heat shock protein 70 kDa and 90 kDa antibodies in serum of patients with rheumatoid arthritis. Ann Rheum Dis. 1999;58(5):291–296
  95. McLean IL, Archer JR, Cawley MI, Pegley FS, Kidd BL, Thompson PW. Specific antibody response to the mycobacterial 65 kDa stress protein in ankylosing spondylitis and rheumatoid arthritis. Br J Rheumatol. 1990;29(6):426–429
  96. Rudolphi U, Hohlbaum A, Lang B, Peter HH, Melchers I. The B cell repertoire of patients with rheumatoid arthritis (Frequencies and specificities of peripheral blood B cells reacting with human IgG, human collagens, a mycobacterial heat shock protein and other antigens). Clin Exp Immunol. 1993;92(3):404–411
  97. Sherer Y, Gerli R, Bocci EB, Gilburd B, Vaudo G, Bistoni O, et al. Heat-shock protein 65 autoantibodies are differently associated with early atherosclerosis in rheumatoid arthritis and in healthy subjects. Ann NY Acad Sci. 2007;1108:408–413
  98. Worthington J, Rigby AS, MacGregor AJ, Silman AJ, Carthy D, Ollier WE. Lack of association of increased antibody levels to mycobacterial hsp65 with rheumatoid arthritis: results from a study of disease discordant twin pairs. Ann Rheum Dis. 1993;52(7):542–544
  99. Roelofs MF, Boelens WC, Joosten LA, Abdollahi-Roodsaz S, Geurts J, Wunderink LU, et al. Identification of small heat shock protein B8 (HSP22) as a novel TLR4 ligand and potential involvement in the pathogenesis of rheumatoid arthritis. J Immunol. 2006;176(11):7021–7027
  100. Kidd BA, Ho PP, Sharpe O, Zhao X, Tomooka BH, Kanter JL, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther. 2008;10(5):R119
  101. Nielen MM, van Schaardenburg D, Reesink HW, van de Stadt RJ, van der Horst-Bruinsma IE, de Koning MH, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50(2):380–386
  102. Quinn MA, Gough AK, Green MJ, Devlin J, Hensor EM, Greenstein A, et al. Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome. Rheumatology (Oxford). 2006;45(4):478–480
  103. Kobayashi H, Takeno M, Saito T, Takeda Y, Kirino Y, Noyori K, et al. Regulatory role of heme oxygenase 1 in inflammation of rheumatoid arthritis. Arthritis Rheum. 2006;54(4):1132–1142
  104. Vanags D, Williams B, Johnson B, Hall S, Nash P, Taylor A, et al. Therapeutic efficacy and safety of chaperonin 10 in patients with rheumatoid arthritis: a double-blind randomised trial. Lancet. 2006;368(9538):855–863
  105. Johnson BJ, Le TT, Dobbin CA, Banovic T, Howard CB, Flores Fde M, et al. Heat shock protein 10 inhibits lipopolysaccharide-induced inflammatory mediator production. J Biol Chem. 2005;280(6):4037–4047
  106. van den Broek TKE, van Wijk F, Ghahramani N, Schechter N, van de Ven A, Albani S. Susceptibility to epitope specific immunotherapy of rheumatoid arthritis relies on the expression of co-stimulatory molecules associated with T cells anergy and tolerance (Abstract number 1848), Abstract supplement 2008 Annual Scientific Meeting. Arthritis Rheum. 2008;58(Suppl 9):845
  107. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, et al. Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J Exp Med. 2004;200(3):277–285
  108. Zanin-Zhorov A, Cahalon L, Tal G, Margalit R, Lider O, Cohen IR. Heat shock protein 60 enhances CD4+ CD25+ regulatory T cell function via innate TLR2 signaling. J Clin Invest. 2006;116(7):2022–2032
  109. De Graeff-Meeder ER, van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JW, et al. Recognition of human 60 kD heat shock protein by mononuclear cells from patients with juvenile chronic arthritis. Lancet. 1991;337(8754):1368–1372
  110. de Graeff-Meeder ER, van Eden W, Rijkers GT, Prakken BJ, Kuis W, Voorhorst-Ogink MM, et al. Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favorable course of arthritis. J Clin Invest. 1995;95(3):934–940
  111. de Kleer IM, Kamphuis SM, Rijkers GT, Scholtens L, Gordon G, De Jager W, et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum. 2003;48(7):2001–2010
  112. Prakken AB, van Eden W, Rijkers GT, Kuis W, Toebes EA, de Graeff-Meeder ER, et al. Autoreactivity to human heat-shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 1996;39(11):1826–1832
  113. Kim EY, Moudgil KD. The determinants of susceptibility/resistance to adjuvant arthritis in rats. Arthritis Res Ther. 2009;11(4):239
  114. Edwards CJ. Commensal gut bacteria and the etiopathogenesis of rheumatoid arthritis. J Rheumatol. 2008;35(8):1477–1497
  115. Barclay AR, Morrison DJ, Weaver LT. What is the role of the metabolic activity of the gut microbiota in inflammatory bowel disease? (Probing for answers with stable isotopes). J Pediatr Gastroenterol Nutr. 2008;46(5):486–495
  116. Vaahtovuo J, Munukka E, Korkeamaki M, Luukkainen R, Toivanen P. Fecal microbiota in early rheumatoid arthritis. J Rheumatol. 2008;35(8):1500–1505
  117. Breban MA, Moreau MC, Fournier C, Ducluzeau R, Kahn MF. Influence of the bacterial flora on collagen-induced arthritis in susceptible and resistant strains of rats. Clin Exp Rheumatol. 1993;11(1):61–64
  118. Moudgil KD, Kim E, Yun OJ, Chi HH, Brahn E, Sercarz EE. Environmental modulation of autoimmune arthritis involves the spontaneous microbial induction of T cell responses to regulatory determinants within heat shock protein 65. J Immunol. 2001;166(6):4237–4243
  119. Toivanen P, Vaahtovuo J, Eerola E. Influence of major histocompatibility complex on bacterial composition of fecal flora. Infect Immun. 2001;69(4):2372–2377
  120. Khachatryan ZA, Ktsoyan ZA, Manukyan GP, Kelly D, Ghazaryan KA, Aminov RI. Predominant role of host genetics in controlling the composition of gut microbiota. PLoS One. 2008;3(8):e3064
  121. Clayton TA, Baker D, Lindon JC, Everett JR, Nicholson JK. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA. 2009;106(34):14728–14733
  122. Hogervorst EJ, Schouls L, Wagenaar JP, Boog CJ, Spaan WJ, et al. Modulation of experimental autoimmunity: treatment of adjuvant arthritis by immunization with a recombinant vaccinia virus. Infect Immun. 1991;59(6):2029–2035
  123. Devesa I, Ferrandiz ML, Busserolles J, Alcaraz MJ. Effects of heme oxygenase-1 inducers on established rat adjuvant arthritis. Cell Mol Biol (Noisy-le-grand). 2005;51(5):479–485
  124. Bloemendal A, Van der Zee R, Rutten VP, van Kooten PJ, Farine JC, van Eden W. Experimental immunization with anti-rheumatic bacterial extract OM-89 induces T cell responses to heat shock protein (hsp)60 and hsp70; modulation of peripheral immunological tolerance as its possible mode of action in the treatment of rheumatoid arthritis (RA). Clin Exp Immunol. 1997;110(1):72–78
  125. Lopez-Guerrero JA, Ortiz MA, Paez E, Bernabeu C, Lopez-Bote JP. Therapeutic effect of recombinant vaccinia virus expressing the 60-kd heat-shock protein on adjuvant arthritis. Arthritis Rheum. 1994;37(10):1462–1467
  126. Prakken BJ, Wendling U, van der Zee R, Rutten VP, Kuis W, van Eden W. Induction of IL-10 and inhibition of experimental arthritis are specific features of microbial heat shock proteins that are absent for other evolutionarily conserved immunodominant proteins. J Immunol. 2001;167(8):4147–4153
  127. Sugita T, Tanaka S, Murakami T, Miyoshi H, Ohnuki T. Immunosuppressive effects of the heat shock protein 90-binding antibiotic geldanamycin. Biochem Mol Biol Int. 1999;47(4):587–595
  128. Barker RN, Webb GR, Thompson SJ, Ghoraishian M, Ponsford FM, Elson CJ. Differential effects of immunisation with mycobacterial 65 kD heat shock protein on two models of autoimmunity. Autoimmunity. 1992;14(1):73–77
  129. Beech JT, Siew LK, Ghoraishian M, Stasiuk LM, Elson CJ, Thompson SJ. CD4+ Th2 cells specific for mycobacterial 65-kilodalton heat shock protein protect against pristine-induced arthritis. J Immunol. 1997;159(8):3692–3697
  130. Ghoraishian M, Elson CJ, Thompson SJ. Comparison between the protective effects of mycobacterial 65-kD heat shock protein and ovomucoid in pristane-induced arthritis: relationship with agalactosyl IgG. Clin Exp Immunol. 1993;94(2):247–251
  131. Santos-Junior RR, Sartori A, De Franco M, Filho OG, Coelho-Castelo AA, Bonato VL, et al. Immunomodulation and protection induced by DNA-hsp65 vaccination in an animal model of arthritis. Hum Gene Ther. 2005;16(11):1338–1345
  132. Thompson SJ, Hitsumoto Y, Ghoraishian M, van der Zee R, Elson CJ. Cellular and humoral reactivity pattern to the mycobacterial heat shock protein hsp65 in pristane induced arthritis susceptible and hsp65 protected DBA/1 mice. Autoimmunity. 1991;11(2):89–95
  133. Willis D, Moore AR, Gowland G, Willoughby A. Polyarthritis in the rat: effects of tolerance and sensitization to the bacterial extract OM-89 with a possible mode of action. Br J Rheumatol. 1995;34(12):1135–1138
  134. Wieten L, Berlo SE, Ten Brink CB, van Kooten PJ, Singh M, van der Zee R, et al. IL-10 is critically involved in mycobacterial HSP70 induced suppression of proteoglycan-induced arthritis. PLoS ONE. 2009;4(1):e4186
  135. Golden HW, Maniglia CA, Ranges GE. A synthetic mycobacterial heat shock peptide prevents adjuvant arthritis but not proteoglycan-induced synovitis in the rat. Agents Actions. 1991;34(1-2):148–150
  136. Hunt DW, Corson L, Barker HD, Levy JG, Petty RE. Relationship between collagen-induced and adjuvant arthritis in the Lewis rat. J Autoimmun. 1993;6(6):691–700
  137. Kurzik-Dumke U, Schick C, Rzepka R, Melchers I. Overexpression of human homologs of the bacterial DnaJ chaperone in the synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum. 1999;42(2):210–220
  138. Dasuri K, Antonovici M, Chen K, Wong K, Standing K, Ens W, et al. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res Ther. 2004;6(2):R161–R168
  139. Kodama E, Kasukawa R, Miyata M, Shigeta S, Ito M. Analysis of human 65 kD heat shock protein mRNA using polymerase chain reaction in synovia of rheumatoid arthritis patients. Fukushima J Med Sci. 1995;41(2):95–102
  140. Sharif M, Worrall JG, Singh B, Gupta RS, Lydyard PM, Lambert C, et al. The development of monoclonal antibodies to the human mitochondrial 60-kd heat-shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum. 1992;35(12):1427–1433
  141. Karlsson-Parra A, Soderstrom K, Ferm M, Ivanyi J, Kiessling R, Klareskog L. Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scand J Immunol. 1990;31(6):283–288
  142. de Graeff-Meeder ER, Voorhorst M, van Eden W, Schuurman HJ, Huber J, Barkley D, et al. Antibodies to the mycobacterial 65-kd heat-shock protein are reactive with synovial tissue of adjuvant arthritic rats and patients with rheumatoid arthritis and osteoarthritis. Am J Pathol. 1990;137(5):1013–1017
  143. Martin CA, Carsons SE, Kowalewski R, Bernstein D, Valentino M, Santiago-Schwarz F. Aberrant extracellular and dendritic cell (DC) surface expression of heat shock protein (hsp)70 in the rheumatoid joint: possible mechanisms of hsp/DC-mediated cross-priming. J Immunol. 2003;171(11):5736–5742
  144. Nguyen TT, Gehrmann M, Zlacka D, Sosna A, Vavrincova P, Multhoff G, et al. Heat shock protein 70 membrane expression on fibroblast-like synovial cells derived from synovial tissue of patients with rheumatoid and juvenile idiopathic arthritis. Scand J Rheumatol. 2006;35(6):447–453
  145. Schett G, Redlich K, Xu Q, Bizan P, Groger M, Tohidast-Akrad M, et al. Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue (Differential regulation of hsp70 expression and hsf1 activation in synovial fibroblasts by proinflammatory cytokines, shear stress, and antiinflammatory drugs). J Clin Invest. 1998;102(2):302–311
  146. Dong W, Li X, Feng Y, Fan C, Chen Z, Zhu P. The differential expressions of 78-kDa glucose regulated protein of infiltrating plasma cells in peripheral joints with the histopathological variants of rheumatoid synovitis. Arthritis Res Ther. 2009;11(1):R4
  147. Schick C, Arbogast M, Lowka K, Rzepka R, Melchers I. Continuous enhanced expression of Hsc70 but not Hsp70 in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2004;50(1):88–93
  148. Sato H, Miyata M, Kasukawa R. Expression of heat shock protein on lymphocytes in peripheral blood and synovial fluid from patients with rheumatoid arthritis. J Rheumatol. 1996;23(12):2027–2032
  149. Kanerud L, Scheynius A, Nord CE, Hafstrom I. Effect of sulphasalazine on gastrointestinal microflora and on mucosal heat shock protein expression in patients with rheumatoid arthritis. Br J Rheumatol. 1994;33(11):1039–1048

 This work was supported by grants from the National Institutes of Health (Bethesda, MD) and the Arthritis Foundation (Atlanta, GA).

 The authors have no conflict of interest to disclose.

PII: S0049-0172(09)00122-X

doi: 10.1016/j.semarthrit.2009.10.002

Seminars in Arthritis and Rheumatism
Volume 40, Issue 2 , Pages 164-175 , October 2010

Article Tools